Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 725
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
70980
Initially I was very disturbed with the PR
(8)
petemantx
12/27/2021 8:38:39 PM
70979
As frustrations mount over the need for, what
(2)
Commando911
12/27/2021 12:52:02 AM
70978
So if you have migraines or certain heart
(3)
Drano
12/27/2021 12:07:13 AM
70977
Ritonavir, part of part of Pfizer's covid pill
(5)
farrell
12/26/2021 11:43:01 PM
70976
Great post farrell. We have all read about safety
(6)
Mo
12/26/2021 11:49:20 AM
70975
At this point none of the other antiviral drugs
(11)
farrell
12/26/2021 10:59:11 AM
70972
Thanks and same to you and the board as well.
(3)
Kelt
12/25/2021 3:14:01 PM
70968
Second the motion. Merry Christmas and let's hope
(5)
Drano
12/25/2021 11:02:42 AM
70967
Merry Christmas to you and all who
(5)
someconcerns
12/25/2021 6:31:36 AM
70966
Merry Christmas, folks!
(5)
Commando911
12/24/2021 10:56:00 PM
70965
Maybe Leo will apply for a NIIMBL grant from the
Commando911
12/23/2021 10:04:23 AM
70961
Response to a post on another board. Post:
(3)
Kelt
12/21/2021 6:03:41 PM
70959
Good information. The "broad spectrum" potential
bandg
12/21/2021 9:14:37 AM
70958
Links:
(2)
farrell
12/21/2021 9:05:24 AM
70956
The multi-identity just wants to soft bash. But
(3)
Drano
12/20/2021 4:29:32 PM
70955
The "Fat Lady" hasn't sung yet on the P2 results
(5)
Kelt
12/20/2021 3:49:14 PM
70954
Brilacidin phase 2 test suggested they did not
(4)
airplaneguy
12/20/2021 3:06:09 PM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
70912
How amusing that the scum multiple identity
(8)
Drano
11/30/2021 10:02:32 AM
70910
How far will scum go to manipulate stock price?
(5)
Drano
11/30/2021 9:48:44 AM
70909
Polymedix's study of its defensin mimetics
(6)
farrell
11/28/2021 12:20:39 PM
70908
Thanks for posting this. Brilacidin performs
KDPMD
11/27/2021 8:02:16 PM
70907
Russian clinical trial past fraud
djs7
11/27/2021 7:12:48 PM
70906
Attached link quite interesting for a number of
(8)
petemantx
11/27/2021 1:56:52 PM
70905
The purported "AlanC" who just posted is NOT the
(10)
Drano
11/23/2021 1:54:06 PM
70903
I agree Glad to finally hear from you.
(2)
Kelt
11/22/2021 7:56:04 PM
70899
Besides trying to hide the real issues with this
(6)
falcon74
11/18/2021 12:53:47 PM
Newer
Older
Recent Articles
Telomir Pharmaceuticals Experiences Surge Following Promising Clinical Trials
SKF's Resilience in Q2 2025 Reflects Strategic Initiatives
SKF's Q2 2025 Results Highlight Strong Operating Margins
Munters Group AB Reports Strong Growth Despite Market Challenges
Danske Bank's Half-Year Results Highlight Solid Performance and Growth
Realkredit Danmark Achieves Impressive Half-Year Profit Milestone
Amazon's Strategic Layoffs in AWS Amid AI Transformation
New Tariffs Challenge Battery Supply Chains for Electric Vehicles
Aker BP Announces Ex-Dividend Payment of USD 0.63 Today
Electrolux Group Q2 2025 Report: Key Highlights and Insights
Husqvarna Group's Q2 2025 Report: Strong Growth and Developments
Solid Financial Growth Despite Market Challenges in 2025
Realkredit Danmark Achieves Record Net Profit in 2025
Electrolux Group Shows Growth and Strategic Focus in Q2 2025
Coop Pank Achieves Steady Growth Amid Economic Challenges
Aker BP Declares Ex-Dividend of $0.63 for Investors
Electrolux Group Shows Growth Amid Market Challenges in Q2 2025
Husqvarna Group's Profitability Improvements in Mid-2025
Sanofi's Strategic Acquisition of Blueprint Medicines Unveiled
Coop Pank Reports Strong Growth in Customer Base and Loans
BW Energy's Q2 2025 Oil Production Insights and Future Plans
Clariant Strongly Denies LyondellBasell's Damages Allegation
Telia Lietuva Reports Impressive Growth in Mid-Year Results
Telenor's Q2 Performance: Strong Growth and Strategic Investments
Sanofi Strengthens Its Portfolio with Blueprint Medicines Deal
Rapidus Breaks Ground in Semiconductor Innovation with 2nm Transistors
Chamath Palihapitiya Critiques AI Trends, Advocates Software Factory
Cryptocurrency Revolution: Trump’s Bold Move for Retirement Funds
Jerome Powell Addresses Concerns on Fed HQ Renovations
How to Build a Winning Team: Insights from an Industry Leader
Gary Black Highlights Uber's Edge in Autonomous Driving Era
Netflix's Strategic Push for YouTube Creators Boosts Revenue
SEMIFIVE Launches Pre-IPO Process to Accelerate Growth
Frequency Holdings YCRM Addresses Court Ruling Impact
Frequency Holdings Clarifies Legal Position Post Judgment Statement
DeepQure Secures Approval for HyperQure Clinical Trials
Meta Platforms Settles Privacy Lawsuit, Avoids Court Drama
WSPN Launches WUSD Stablecoin on Coins.ph for PHP Users
Elon Musk's Grok Faces Criticism for Political Bias Issues
Cryptocurrency Surge: Bitcoin and Ethereum Gain Traction
EFGH Expands Operations in Africa with Strategic Innovations
MindHYVE.ai™ and AI Future Lab Launch Unique Education Initiative
Important Reminder on Avoiding Unofficial Communications
Simply Solventless Initiates Retrofit to Boost Cannabis Production
CenterPoint Energy Announces Cash Dividend for Shareholders
NTT DATA Earns Recognition for Leading Generative AI Solutions
Mesoblast's Ryoncil® Achieves Notable Commercial Success
GARVEE.com Drives E-commerce Success with Strategic Growth Moves
Discover Petomg's Stylish and Ethical Cat Furniture Collection
Mesoblast Reports Strong Ryoncil® Launch Financials and Outlook